A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study

Peer Review reports

Original Submission
30 Nov 2017	Submitted	Original manuscript
19 Mar 2018	Reviewed	Reviewer Report - Luigia Scudeller
22 Mar 2018	Reviewed	Reviewer Report - Maarten van Smeden
16 Apr 2018	Author responded	Author comments - Shirin Kalimuddin
Resubmission - Version 2
16 Apr 2018	Submitted	Manuscript version 2
23 Apr 2018	Reviewed	Reviewer Report - Luigia Scudeller
30 Apr 2018	Reviewed	Reviewer Report - Maarten van Smeden
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
21 May 2018	Editorially accepted
1 Jun 2018	Article published	10.1186/s13063-018-2702-8

Back to article page